放射性颌骨坏死治疗策略研究进展

doi:10.13591/j.cnki.kqyx.2024.11.013

摘要/Abstract

摘要：

头颈部恶性肿瘤是全球范围内的第七大常见肿瘤,约占全部恶性肿瘤的10%,放射治疗是头颈部恶性肿瘤的重要治疗方案。放射性颌骨坏死(osteoradionecrosis of the jaws, ORNJ)是一种头颈部恶性肿瘤放疗后出现的难治并发症,常表现出颌骨坏死和软组织暴露。当前ORNJ的发病机制尚未完全明确,其治疗仍具有挑战性。该病传统的治疗方式为部分切除坏死颌骨结合骨皮瓣重建。但近年来,一些新技术、新思路被用于治疗该疾病,对于程度较轻的放射性颌骨坏死,治疗理念趋于保守。本文主要归纳国内外最新研究进展,对放射性颌骨坏死的发病机制、临床表现和治疗策略进行综述。

关键词: 放射性颌骨坏死, 间充质干细胞, 虚拟手术设计

Abstract:

Head and neck cancer is the seventh most common cancer in the world, accounting for about 10% of all malignant tumors. Radiotherapy is an important treatment for head and neck cancer. Osteonecrosis of the jaws(ORNJ) is a refractory complication after radiotherapy for head and neck cancer, which often manifests as osteonecrosis of the jaw and soft tissue exposure. The current pathogenesis of ORNJ has not been fully clarified and its treatment remains challenging. The traditional treatment for this disease is partial resection of necrotic jaw bone and reconstruction with osteocutaneous flap. However, in recent years, some new techniques and ideas have been used to treat the disease. For mild osteoradionecrosis of the jaw, the treatment concept tends to be conservative. This article mainly summarizes the latest research progress at home and abroad, and reviews the pathogenesis, clinical manifestations and treatment strategies for osteoradionecrosis of the jaws.

Key words: osteonecrosis of the jaws, mesenchymal stem cells, virtual surgical planning

中图分类号:

R782.32

王希锐, 朱慧勇. 放射性颌骨坏死治疗策略研究进展[J]. 口腔医学, 2024, 44(11): 864-870.

WANG Xirui, ZHU Huiyong. Research progress of treatment strategies for osteoradionecrosis of the jaws[J]. Stomatology, 2024, 44(11): 864-870.

参考文献 55

[1]	Chow LQM. Head and neck cancer[J]. N Engl J Med, 2020, 382(1): 60-72.
[2]	Chronopoulos A, Zarra T, Ehrenfeld M, et al. Osteoradionecrosis of the jaws: Definition, epidemiology, staging and clinical and radiological findings. A concise review[J]. Int Dent J, 2018, 68(1): 22-30. doi: 10.1111/idj.12318 pmid: 28649774
[3]	Moon DH, Moon SH, Wang K, et al. Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers[J]. Oral Oncol, 2017, 72: 98-103. doi: S1368-8375(17)30205-1 pmid: 28797468
[4]	Wong ATT, Lai SY, Gunn GB, et al. Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis[J]. Oral Oncol, 2017, 66: 75-80. doi: S1368-8375(17)30013-1 pmid: 28249651
[5]	Jawad H, Hodson NA, Nixon PJ. A review of dental treatment of head and neck cancer patients, before, during and after radiotherapy: Part 2[J]. Br Dent J, 2015, 218(2): 69-74.
[6]	Miniello TG, Araújo JP, Silva MLG, et al. Influence of bisphosphonates on clinical features of osteoradionecrosis of the maxilla and mandible[J]. Oral Dis, 2019, 25(5): 1344-1351. doi: 10.1111/odi.13081 pmid: 30821889
[7]	Sijtsema ND, Verduijn GM, Nasserinejad K, et al. Development of a local dose-response relationship for osteoradionecrosis within the mandible[J]. Radiother Oncol, 2023, 186: 109736.
[8]	Watson EE, Hueniken K, Lee J, et al. Development and standardization of a classification system for osteoradionecrosis: Implementation of a risk-based model[J]. Med Rxiv, 2023: 2023.09.12.23295454.
[9]	Owosho AA, Tsai CJ, Lee RS, et al. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience[J]. Oral Oncol, 2017, 64: 44-51. doi: S1368-8375(16)30223-8 pmid: 28024723
[10]	Kabir R, Durand R, Roberge D, et al. Incidence of osteoradionecrosis of the jaws: A retrospective study of 620 patients with head and neck cancer[J]. Gen Dent, 2022, 70(4): 72-77. pmid: 35749251
[11]	Meyer I. Infectious diseases of the jaws[J]. J Oral Surg, 1970, 28(1): 17-26.
[12]	Marx RE. Osteoradionecrosis: A new concept of its pathophysiology[J]. J Oral Maxillofac Surg, 1983, 41(5): 283-288.
[13]	Marx RE. A new concept in the treatment of osteoradionecrosis[J]. J Oral Maxillofac Surg, 1983, 41(6): 351-357.
[14]	Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: Therapeutic perspective via the antioxidant pathway[J]. Radiother Oncol, 2004, 73(2): 119-131. doi: 10.1016/j.radonc.2004.08.021 pmid: 15542158
[15]	Chang DT, Sandow PR, Morris CG, et al. Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible?[J]. Head Neck, 2007, 29(6): 528-536.
[16]	Mitsimponas KT, Moebius P, Amann K, et al. Osteo-radio-necrosis (ORN) and bisphosphonate-related osteonecrosis of the jaws (BRONJ): The histopathological differences under the clinical similarities[J]. Int J Clin Exp Pathol, 2014, 7(2): 496-508.
[17]	Wang Z, Xu JM, Wan JB, et al. Vascular analysis of soft tissues around the bone lesion in osteoradionecrosis, medication-related osteonecrosis, and infectious osteomyelitis of the jaw[J]. J Craniofac Surg, 2022, 33(7): e750-e754. doi: 10.1097/SCS.0000000000008697 pmid: 36201691
[18]	Wang Y, Zhu GY, Wang JP, et al. Irradiation alters the differentiation potential of bone marrow mesenchymal stem cells[J]. Mol Med Rep, 2016, 13(1): 213-223. doi: 10.3892/mmr.2015.4539 pmid: 26572960
[19]	Zhang R, Wang ZL, Zhu GX, et al. Low-intensity pulsed ultrasound modulates RhoA/ROCK signaling of rat mandibular bone marrow mesenchymal stem cells to rescue their damaged cytoskeletal organization and cell biological function induced by radiation[J]. Stem Cells Int, 2020, 2020: 8863577.
[20]	Taeb S, Mosleh-Shiraz MA, Ghaderi A, et al. Adipose-derived mesenchymal stem cells responses to different doses of gamma radiation[J]. J Biomed Phys Eng, 2022, 12(1): 35-42. doi: 10.31661/jbpe.v0i0.1212 pmid: 35155291
[21]	Filion TM, Qiao M, Ghule PN, et al. Survival responses of human embryonic stem cells to DNA damage[J]. J Cell Physiol, 2009, 220(3): 586-592. doi: 10.1002/jcp.21735 pmid: 19373864
[22]	何悦, 侯劲松, 李晓光, 等. 下颌骨放射性骨坏死临床诊疗专家共识[J]. 中国口腔颌面外科杂志, 2017, 15(5): 445-456.
[23]	Lin ZC, Bennett MH, Hawkins GC, et al. Hyperbaric oxygen therapy for late radiation tissue injury[J]. Cochrane Database Syst Rev, 2023, 8(8): CD005005.
[24]	Shaw RJ, Butterworth C. Hyperbaric oxygen in the management of late radiation injury to the head and neck. Part Ⅱ: Prevention[J]. Br J Oral Maxillofac Surg, 2011, 49(1): 9-13.
[25]	Nabil S, Samman N. Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: A systematic review[J]. Int J Oral Maxillofac Surg, 2011, 40(3): 229-243.
[26]	Sultan A, Hanna GJ, Margalit DN, et al. The use of hyperbaric oxygen for the prevention and management of osteoradionecrosis of the jaw: A Dana-farber/brigham and women’s cancer center multidisciplinary guideline[J]. Oncologist, 2017, 22(11): 1413. doi: 10.1634/theoncologist.2016-0298erratum pmid: 29123016
[27]	Shaw RJ, Butterworth CJ, Silcocks P, et al. HOPON (hyperbaric oxygen for the prevention of osteoradionecrosis): A randomized controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible after dentoalveolar surgery[J]. Int J Radiat Oncol Biol Phys, 2019, 104(3): 530-539.
[28]	Delanian S, Chatel C, Porcher R, et al. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): A phase Ⅱ trial[J]. Int J Radiat Oncol Biol Phys, 2011, 80(3): 832-839.
[29]	Vorakulpipat P, Suphangul S, Fuangtharnthip P, et al. Combination of advanced platelet-rich fibrin and pentoxifylline/tocopherol as a novel preventive option in osteoradionecrosis: A case report[J]. Eur J Dent, 2023, 17(1): 250-254.
[30]	Patel V, Young H, Mellor A, et al. The use of liquid formulation pentoxifylline and vitamin E in both established and as a prophylaxis for dental extractions “at risk” of osteoradionecrosis[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2023, 136(4): 404-409.
[31]	Vagish Kumar LS. Propolis in dentistry and oral cancer management[J]. N Am J Med Sci, 2014, 6(6): 250-259.
[32]	Çolak S, Erdil A, Gevrek F. Effects of systemic Anatolian propolis administration on a rat-irradiated osteoradionecrosis model[J]. J Appl Oral Sci, 2023, 31: e20230231.
[33]	Khalil MI, Sulaiman SA, Boukraa L. Antioxidant properties of honey and its role in preventing health disorder[J]. Open Nutraceuticals J, 2010, 3(1): 6-16.
[34]	Zhuang XM, Zhou B. Exosome secreted by human gingival fibroblasts in radiation therapy inhibits osteogenic differentiation of bone mesenchymal stem cells by transferring miR-23a[J]. Biomed Pharmacother, 2020, 131: 110672.
[35]	Deshpande SS, Gallagher KK, Donneys A, et al. Stem cell therapy remediates reconstruction of the craniofacial skeleton after radiation therapy[J]. Stem Cells Dev, 2013, 22(11): 1625-1632. doi: 10.1089/scd.2012.0472 pmid: 23282102
[36]	Park HS, Lee J, Kim JW, et al. Preventive effects of tonsil-derived mesenchymal stem cells on osteoradionecrosis in a rat model[J]. Head Neck, 2018, 40(3): 526-535.
[37]	Zheng B, Mao CY, Gu TY, et al. Phosphorylated chitosan to promote biomimetic mineralization of type I collagen as a strategy for dentin repair and bone tissue engineering[J]. New J Chem, 2019, 43(4): 2002-2010. doi: 10.1039/c8nj04889d
[38]	Janus JR, Jackson RS, Lees KA, et al. Human adipose-derived mesenchymal stem cells for osseous rehabilitation of induced osteoradionecrosis: A rodent model[J]. Otolaryngol Head Neck Surg, 2017, 156(4): 616-621. doi: 10.1177/0194599816688647 pmid: 28116973
[39]	Gundestrup AK, Lynggaard CD, Forner L, et al. Mesenchymal stem cell therapy for osteoradionecrosis of the mandible: A systematic review of preclinical and human studies[J]. Stem Cell Rev Rep, 2020, 16(6): 1208-1221.
[40]	Manimaran K, Sankaranarayanan S, Ravi VR, et al. Treatment of osteoradionecrosis of mandible with bone marrow concentrate and with dental pulp stem cells[J]. Ann Maxillofac Surg, 2014, 4(2): 189-192. doi: 10.4103/2231-0746.147130 pmid: 25593871
[41]	Guo ZY, Wang ZL, Liu YG, et al. Carbon dots from Lycium barbarum attenuate radiation-induced bone injury by inhibiting senescence via METTL3/Clip3 in an m⁶A-dependent manner[J]. ACS Appl Mater Interfaces, 2023, 15(17): 20726-20741.
[42]	刘仰, 孔祥波, 李洁, 等. α2-巨球蛋白减轻X射线所致人骨髓间充质干细胞成骨分化障碍[J]. 中国病理生理杂志, 2017, 33(11): 2032-2037.
[43]	Liu Y, Cao WT, Kong XB, et al. Protective effects of α-2-macroglobulin on human bone marrow mesenchymal stem cells in radiation injury[J]. Mol Med Rep, 2018, 18(5): 4219-4228.
[44]	Li J, Yin P, Chen XY, et al. Effect of α2-macroglobulin in the early stage of jaw osteoradionecrosis[J]. Int J Oncol, 2020, 57(1): 213-222.
[45]	李洁, 孔祥波, 陈雪英, 等. α2巨球蛋白对大鼠下颌骨放射性骨坏死的预防作用[J]. 中国口腔颌面外科杂志, 2018, 16(2): 126-131.
[46]	Oh H, Kwon D, Ahn J, et al. Reconstruction of mandibular defects in osteoradionecrosis and medication-related osteonecrosis of the jaw using fibula free flap and management of postoperative wound infections[J]. Maxillofac Plast Reconstr Surg, 2022, 44(1): 37. doi: 10.1186/s40902-022-00366-2 pmid: 36484930
[47]	Barr ML, Haveles CS, Rezzadeh KS, et al. Virtual surgical planning for mandibular reconstruction with the Fibula free flap: A systematic review and meta-analysis[J]. Ann Plast Surg, 2020, 84(1): 117-122. doi: 10.1097/SAP.0000000000002006 pmid: 31633539
[48]	Annino DJ Jr, Hansen EE, Sethi RK, et al. Accuracy and outcomes of virtual surgical planning and 3D-printed guides for osseous free flap reconstruction of mandibular osteoradionecrosis[J]. Oral Oncol, 2022, 135: 106239.
[49]	Hanasono MM, Skoracki RJ. Computer-assisted design and rapid prototype modeling in microvascular mandible reconstruction[J]. Laryngoscope, 2013, 123(3): 597-604.
[50]	Lin CH, Hsu CH, Adarsh K, et al. Real-time intraoperative computed tomography can accurize virtual surgical planning on the double-barrel fibular flap for mandibular reconstruction[J]. J Plast Reconstr Aesthet Surg, 2022, 75(8): 2702-2705.
[51]	Aljohani S, Fliefel R, Brunner TF, et al. Fluorescence-guided surgery for osteoradionecrosis of the jaw: A retrospective study[J]. J Int Med Res, 2022, 50(6): 3000605221104186.
[52]	Straub A, Stapf M, Fischer M, et al. Bone concentration of ampicillin/sulbactam: A pilot study in patients with osteonecrosis of the jaw[J]. Int J Environ Res Public Health, 2022, 19(22): 14917.
[53]	Ribeiro GH, Minamisako MC, Rath IBDS, et al. Osteoradionecro-sis of the jaws: Case series treated with adjuvant low-level laser therapy and antimicrobial photodynamic therapy[J]. J Appl Oral Sci, 2018, 26: e20170172.
[54]	Campos L, Martins F, Tateno RY, et al. Antimicrobial photodynamic therapy using optical fiber for oral fistula resulting from mandibular osteoradionecrosis[J]. Photodiagnosis Photodyn Ther, 2021, 34: 102247.
[55]	Qualliotine JR, Yousef A, Orosco RK, et al. Carbon dioxide laser sequestrectomy for osteoradionecrosis: A case series[J]. Photobiomodul Photomed Laser Surg, 2023, 41(2): 73-79. doi: 10.1089/photob.2022.0090 pmid: 36780577